A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics

Por Hodsman, Peter, Ashman, Claire, Cahn, Anthony, De Boever, Erika, Locantore, Nicholas, Serone, Adrian, Pouliquen, Isabelle
Publicado em 2013

Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects

Por Martin, Kevin J., Bell, Gregory, Pickthorn, Karen, Huang, Saling, Vick, Andrew, Hodsman, Peter, Peacock, Munro
Publicado em 2014

Intravenous Pharmacokinetics, Local Tolerability, and Hemolysis of an SBE7-β-Cyclodextrin Formulation of the Neurokinin-1 Receptor Antagonist Vestipitant

Por Brigandi, Richard A, Russ, Steven F, Petit, Chantal, Johnson, Brendan, Croy, Scott, Hodsman, Peter, Muller, Fran
Publicado no Clin Pharmacol Drug Dev (2015)

SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans

Por Price, Clare F., Tyssen, David, Sonza, Secondo, Davie, Ashley, Evans, Sonya, Lewis, Gareth R., Xia, Shirley, Spelman, Tim, Hodsman, Peter, Moench, Thomas R., Humberstone, Andrew, Paull, Jeremy R.A., Tachedjian, Gilda
Publicado em 2011